首页> 外国专利> monoclonal antibody or antigen-binding fragment thereof, isolated nucleic acid molecule, vector, host cell, method for making monoclonal antibody or antigen-binding fragment thereof, conjugate, antibody conjugate hybridoma cell strain lt005 bifunctional, multispecific antibody, pharmaceutical composition and use of the monoclonal antibody or antigen-binding fragment thereof

monoclonal antibody or antigen-binding fragment thereof, isolated nucleic acid molecule, vector, host cell, method for making monoclonal antibody or antigen-binding fragment thereof, conjugate, antibody conjugate hybridoma cell strain lt005 bifunctional, multispecific antibody, pharmaceutical composition and use of the monoclonal antibody or antigen-binding fragment thereof

机译:单克隆抗体或其抗原结合片段,分离的核酸分子,载体,宿主细胞,制备单克隆抗体或其抗原结合片段的方法,偶联物,双功能抗体偶联物杂交瘤细胞株lt005,多特异性抗体,药物组合物及其用途单克隆抗体或其抗原结合片段

摘要

The present invention belongs to the field of tumor therapy and molecular immunology and relates to a pdl-1 antibody, a pharmaceutical composition thereof and use thereof. in particular, the present invention relates to a pdl-1 monoclonal antibody or antigen-binding fragment thereof, wherein the monoclonal antibody has a heavy chain variable region comprising cdrs as represented by: 15-17 ; and / or have a light chain variable region comprising cdrs as depicted in sequence: 18-20. The monoclonal antibody of the present invention may specifically bind to pdl-1 and specifically remove pdl-1 immunosuppressive function and activate t-lymphocytes.
机译:本发明属于肿瘤治疗和分子免疫学领域,涉及一种pdl-1抗体,其药物组合物及其用途。特别地,本发明涉及一种pdl-1单克隆抗体或其抗原结合片段,其中所述单克隆抗体具有包含cdrs的重链可变区,如以下由15-17表示;和/或具有包含cdrs的轻链可变区,如序列:18-20所示。本发明的单克隆抗体可以与pdl-1特异性结合并特异性去除pdl-1的免疫抑制功能并激活t淋巴细胞。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号